
|Articles|October 1, 1996
The American Journal of Managed Care
- October 1996
- Volume 2
- Issue 9
Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective
Advertisement
Articles in this issue
about 29 years ago
The Influence of New Devices on the Costs of Interventional Proceduresabout 29 years ago
Patterns of Antidepressant Use and Their Relation to Costs of Careabout 29 years ago
The Psychopharmacology of Depression in the Managed Care Settingabout 29 years ago
Cost-Effective Treatment of DepressionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Combined Eosinophil, CT Measures Predict Smell Recovery After CRSwNP Surgery
3
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
4
Measles Outbreaks Cause Financial, Public Health Burden in US
5















































